Medeon Biodesign (6499) — Financial Flexibility Index
Medeon Biodesign (6499) has a Financial Flexibility Index of -0.46x as of June 2025. Free cash flow of NT$-131.51 Million (operating CF NT$-133.97 Million minus capex NT$2.46 Million) represents 0% of total liabilities (NT$284.53 Million). Also explore net asset momentum of Medeon Biodesign to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medeon Biodesign Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Medeon Biodesign across 8 annual periods. Check 6499 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Medeon Biodesign (2017–2024)
Year-by-year free cash flow to debt coverage for Medeon Biodesign. For the full company profile including market capitalisation, see Medeon Biodesign (6499) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.22x | NT$-757.89 Million | NT$-832.66 Million | NT$341.84 Million | ▼ -19.1% |
| 2023 | -1.86x | NT$-699.26 Million | NT$-755.08 Million | NT$375.65 Million | ▼ -118.5% |
| 2022 | -0.85x | NT$-320.77 Million | NT$-461.34 Million | NT$376.48 Million | ▲ +47.4% |
| 2021 | -1.62x | NT$-285.06 Million | NT$-293.38 Million | NT$176.00 Million | ▼ -723.7% |
| 2020 | -0.20x | NT$-131.11 Million | NT$-151.27 Million | NT$666.83 Million | ▲ +72.7% |
| 2019 | -0.72x | NT$-193.09 Million | NT$-241.99 Million | NT$268.18 Million | ▼ -128.7% |
| 2018 | 2.51x | NT$373.19 Million | NT$322.05 Million | NT$148.89 Million | ▲ +262.9% |
| 2017 | -1.54x | NT$-162.21 Million | NT$-310.76 Million | NT$105.41 Million | — |